- Home
- MREO vs EXFY Comparison
MREO vs EXFY Comparison
Compare MREO & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- EXFY
- Stock Information
- Founded
- MREO 2015
- EXFY 2008
- Country
- MREO United Kingdom
- EXFY United States
- Employees
- MREO N/A
- EXFY N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- EXFY Computer Software: Prepackaged Software
- Sector
- MREO Health Care
- EXFY Technology
- Exchange
- MREO Nasdaq
- EXFY Nasdaq
- Market Cap
- MREO 369.2M
- EXFY 309.9M
- IPO Year
- MREO N/A
- EXFY 2021
- Fundamental
- Price
- MREO $2.30
- EXFY $2.78
- Analyst Decision
- MREO Strong Buy
- EXFY Buy
- Analyst Count
- MREO 7
- EXFY 4
- Target Price
- MREO $7.71
- EXFY $5.00
- AVG Volume (30 Days)
- MREO 1.7M
- EXFY 338.3K
- Earning Date
- MREO 05-14-2025
- EXFY 05-08-2025
- Dividend Yield
- MREO N/A
- EXFY N/A
- EPS Growth
- MREO N/A
- EXFY N/A
- EPS
- MREO N/A
- EXFY N/A
- Revenue
- MREO N/A
- EXFY $139,236,000.00
- Revenue This Year
- MREO N/A
- EXFY $9.56
- Revenue Next Year
- MREO $61.92
- EXFY $6.86
- P/E Ratio
- MREO N/A
- EXFY N/A
- Revenue Growth
- MREO N/A
- EXFY N/A
- 52 Week Low
- MREO $1.58
- EXFY $1.24
- 52 Week High
- MREO $5.02
- EXFY $4.13
- Technical
- Relative Strength Index (RSI)
- MREO 52.99
- EXFY 42.68
- Support Level
- MREO $1.58
- EXFY $2.65
- Resistance Level
- MREO $2.37
- EXFY $2.87
- Average True Range (ATR)
- MREO 0.21
- EXFY 0.21
- MACD
- MREO 0.04
- EXFY 0.01
- Stochastic Oscillator
- MREO 91.19
- EXFY 47.62
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About EXFY Expensify Inc.
Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app.